Opaleye Management Inc. Rezolute, Inc. Transaction History
Opaleye Management Inc.
- $364 Million
- Q1 2025
A detailed history of Opaleye Management Inc. transactions in Rezolute, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 465,000 shares of RZLT stock, worth $2.24 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
465,000
Previous 465,000
-0.0%
Holding current value
$2.24 Million
Previous $2.22 Million
39.22%
% of portfolio
0.37%
Previous 0.44%
Shares
2 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$54.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$11.4 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$10.2 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$8.89 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.41 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $187M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...